http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0055298-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3e5d31bb4619110805c2135e4865c5c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M41-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M41-46
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-483
filingDate 2000-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_703840c3ce3041b8621ee4350424a0f1
publicationDate 2000-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0055298-A1
titleOfInvention Cell activity assay apparatus and methods for making and using same
abstract A cell activity assay apparatus ('CAAA') and method using electromagnetic radiation detection beams to measure the cell activity, e.g., chemotactic response, includes an opaque membrane having a plurality of off-axis pores which prevent experimentally significant amounts of the electromagnetics radiation from traversing the membrane. The membrane is fabricated from opaque films that have been either ablated with substantially off axis excimer laser electromagnetic radiation to form pores, or bombarded by substantially off-axis charged particles and then etched to form pores.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017015337-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2718690-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012170880-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1786921-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10384207-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012170880-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8129175-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7547525-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8486655-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8673628-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1786921-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11071983-B2
priorityDate 1999-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5601997-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5210021-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412143
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136096498
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65079

Total number of triples: 35.